「net」の検索結果

Extract employee, employer, gross pay, INPS/IRPEF deductions, and net pay from Italian payslips.

日本語の概要は準備中です。原文の説明を表示しています。

Explores a CARLA map's road network through the Map/Waypoint API — a natural-language rundown of the whole map ("give me the topology"), drawing the topology to confirm the modelled map matches the visible one, enumerating junctions to resolve phrases like "the 4-way junction in the middle", nearest-waypoint lane facts, and next/previous lane navigation. Use when the user asks about the map's layout, lanes, junctions, topology, or to locate/navigate specific map elements.

日本語の概要は準備中です。原文の説明を表示しています。

Inspects and visualises a ROS-2-enabled CARLA server from Docker containers, with no local ROS 2 install — list/echo/rate-check topics (the "are the topics actually on the wire" check), run the bundled map-and-lidar demo stack (hero vehicle with camera/lidar/GNSS/IMU on autopilot), and open RViz2 with the lane-network preset. Use when the user asks to "check the ROS topics", "echo /carla/map", "is CARLA publishing to ROS", "visualise the lidar in RViz", "open rviz", or "run the ROS 2 demo".

日本語の概要は準備中です。原文の説明を表示しています。

Deploys infrastructure on Oracle Cloud Infrastructure (OCI) with ARM64 instances (Always Free tier eligible). Handles compartments, VCNs, subnets, security lists, and compute instances. Use when: setting up Oracle Cloud infrastructure, deploying ARM64 instances, troubleshooting OUT_OF_HOST_CAPACITY errors, optimizing for Always Free tier. Keywords: oracle cloud, OCI, ARM64, VM.Standard.A1.Flex, Always Free tier, OUT_OF_HOST_CAPACITY, oci compartment, oci vcn

日本語の概要は準備中です。原文の説明を表示しています。

Manage Linux systems covering systemd services, process management, filesystems, networking, performance tuning, and troubleshooting. Use when deploying applications, optimizing server performance, diagnosing production issues, or managing users and security on Linux servers.

日本語の概要は準備中です。原文の説明を表示しています。

Measure ad effectiveness with privacy-preserving attribution using AdAttributionKit. Use when registering ad impressions, handling attribution postbacks, updating conversion values, implementing re-engagement attribution, configuring publisher or advertiser apps, or replacing SKAdNetwork with AdAttributionKit for ad measurement.

日本語の概要は準備中です。原文の説明を表示しています。

Provide comprehensive techniques for attacking Microsoft Active Directory environments. Covers reconnaissance, credential harvesting, Kerberos attacks, lateral movement, privilege escalation, and domain dominance for red team operations and penetration testing.

日本語の概要は準備中です。原文の説明を表示しています。

Generates scheduled background jobs using Quartz.NET. Includes job definitions, triggers, cron scheduling, dependency injection, and persistent job store configuration.

日本語の概要は準備中です。原文の説明を表示しています。

Configures JWT Bearer authentication for .NET APIs. Includes token generation, validation, refresh tokens, and user context extraction from claims.

日本語の概要は準備中です。原文の説明を表示しています。

Evolve this harness with Darwin Mode — frozen model, evolving harness (real, sandboxed, safety-gated).

日本語の概要は準備中です。原文の説明を表示しています。

Put two or more Japanese job offers on one basis so they can be read side by side, separating fixed overtime allowance and unguaranteed bonus from the stated annual figure, converting each offer to guaranteed annual pay and to an hourly rate that includes deemed overtime hours, and listing non-monetary terms without scoring them. Use when a user holds more than one offer, wants to know what a stated 年収 actually contains, or wants to see where the ranking changes once the components are separated; do not use to recommend which offer to accept, to score or rank offers, to estimate take-home pay as fact, or to reply to an employer.

日本語の概要は準備中です。原文の説明を表示しています。

Triage a single GitHub PR by PR number. Check out the PR's branch, detect conflicts with the target branch via `gh pr status` (and label the PR with `cc-resolve-conflict` if any are found), collect unresolved review comments and CI status and judge only whether each item must be fixed, then take action (add cc-fix-onetime label if fixes are needed; if release-ready, add cc-release-ready label for an Epic PR marked `cc-epic-issue` instead of merging, otherwise merge the PR).

日本語の概要は準備中です。原文の説明を表示しています。

Manage your HoneyComb exchange account. Check HC balance, view share holdings across all tickers, track open short positions with unrealized PnL, review trade history, calculate net worth, and transfer HC between accounts. Use when checking balances, reviewing positions, or managing funds.

日本語の概要は準備中です。原文の説明を表示しています。

Read a liarjs fingerprint report and attribute each failing check to the component that produced it - what the check id measures, whether the signal comes from the launch configuration, the page-modifying layer, the network path or the machine image, and which failures are inherent to headless or datacenter environments. Use when a fingerprint scan came back with a low score, or when a check id such as webdriver, worker-consistency, gpu-triad, native-integrity or tz needs explaining.

日本語の概要は準備中です。原文の説明を表示しています。

Work on lyrics — the web fallback (LRCLIB, Musixmatch, NetEase, Genius), the in-memory cache, verification, and embedding lyrics into audio file tags. Use this whenever a task touches `services/lyrics.py`, `services/tags.py`, the `/lyrics.json` route, or `scripts/embed_lyrics.py` / `embed_lyrics_cron.sh` — adding or fixing a provider, changing caching/verification, or the batch tagger. Covers the provider contract, the synced-vs-plain rule, the read-only cache, and why writes only ever store plain text.

日本語の概要は準備中です。原文の説明を表示しています。

Predict peptide-MHC class I binding and natural presentation with MHCflurry, NetMHCpan-4.1, and MixMHCpred to nominate candidate CD8 T-cell epitopes. Covers the binding-affinity (BA) vs eluted-ligand (EL/presentation) distinction, why %Rank beats raw nM for cross-allele work, the MS abundance bias that misranks low-expression neoantigens, allele-coverage inequity, and length bias. Use when scanning a protein or peptide set for class I epitopes, scoring neoantigen candidates, or choosing a binding predictor. For CD4/HLA class II see mhc-class-ii-prediction.

日本語の概要は準備中です。原文の説明を表示しています。

Predict B-cell and T-cell epitopes for vaccine antigen design and epitope mapping with BepiPred-3.0, DiscoTope-3.0, the IEDB tools, and EL-mode MHC presentation. Encodes the load-bearing asymmetry that T-cell epitope prediction is mature (it reduces to MHC presentation, AUC>0.9) while B-cell prediction is unreliable (linear predictors ~AUC 0.6 because ~90% of real epitopes are conformational) — so structure-based DiscoTope-3.0 on AlphaFold models is the only defensible B-cell path, propensity scales are obsolete, and NetChop is largely redundant on EL-trained models. Use when mapping epitopes or selecting vaccine antigens. MHC binding lives in mhc-binding-prediction.

日本語の概要は準備中です。原文の説明を表示しています。

Orders and orients assembled contigs into chromosome-scale scaffolds from long-range linking data, inserting N-gap spacers (adds no sequence). Covers Hi-C/Omni-C scaffolding (YaHS, SALSA2, 3D-DNA/Juicer), Hi-C read-mapping prerequisites (map each end separately, no mate rescue, dedup, enzyme-aware), reading the contact map for misjoins/inversions/false-duplications, manual curation in Juicebox/PretextView (the VGP/DToL standard), reference-guided scaffolding (RagTag) and its karyotype-erasure hazard, genetic-map (ALLMAPS) and Bionano optical-map integration, chimera-breaking before scaffolding, gap-filling, and telomere/contig-vs-scaffold-N50 QC (tidk). Use when turning contigs into chromosomes with Hi-C, integrating a linkage map or optical map, choosing a scaffolder by available linking data, or judging whether a chromosome-scale assembly is trustworthy.

日本語の概要は準備中です。原文の説明を表示しています。

Predict peptide-MHC class II (HLA-DR/DQ/DP) binding and presentation for CD4 T-cell epitopes with NetMHCIIpan-4.3 and MixMHC2pred-2.0. Covers why class II is far less reliable than class I (open binding groove, 9-mer register ambiguity, sparse noisy training data, DR>DP>DQ accuracy asymmetry), the DQ/DP heterodimer alpha/beta pairing trap, and the looser 1%/5% %Rank thresholds. Use when predicting CD4 epitopes for vaccine help, mapping class II neoantigens, or scoring long peptides against DR/DQ/DP. For CD8/class I see mhc-binding-prediction.

日本語の概要は準備中です。原文の説明を表示しています。

Detects acquired antimicrobial-resistance determinants and chromosomal point-mutation resistance in bacterial assemblies using AMRFinderPlus, ResFinder 4.0 (acquired + PointFinder), CARD-RGI, abritAMR, staramr, and species-specific callers (TB-Profiler, Mykrobe). Harmonises cross-tool output via hAMRonization, contextualises determinants with mobile-genetic-element annotation (MOB-suite, PlasmidFinder, MobileElementFinder, ICEberg), predicts phenotype against EUCAST or CLSI breakpoints, and translates calls into WHO GLASS reporting categories. Use when screening clinical or surveillance isolates for AMR, distinguishing acquired vs intrinsic vs point-mutation resistance, calling rpoB / katG / pncA / gyrA / mgrB mutations, reconciling AMRFinderPlus vs RGI vs ResFinder disagreement, contextualising carbapenemases or mcr alleles on plasmids, predicting susceptibility from genotype against the WHO Mtb 2nd-edition catalogue, or building a hAMRonized multi-lab AMR surveillance pipeline.

日本語の概要は準備中です。原文の説明を表示しています。

Infers person-to-person transmission from pathogen genomes using outbreaker2 (Campbell 2018), TransPhylo (Didelot 2017), phybreak (Klinkenberg 2017), BadTrIP (De Maio 2018), SCOTTI (De Maio 2016), BEASTLIER (Hall 2015), and SNP-distance / cluster-picker approaches (HIV-TRACE for HIV; transcluster). Defines outbreak clusters using pathogen-specific SNP thresholds (NOT a universal cutoff -- TB <=12 SNPs / Walker 2013; MRSA <=15 / Coll 2017; C. difficile <=2 / Eyre 2013; Klebsiella <=21 / Snitkin 2012), models within-host diversity and transmission bottlenecks (Worby-Lipsitch-Hanage 2014; McCrone 2018; Sobel Leonard 2017; Lythgoe 2021 SARS-CoV-2), integrates contact-tracing data, distinguishes generation interval from serial interval (Britton & Scalia Tomba 2019; Ali 2020), attributes source via Bayesian source attribution (Mather 2013 DT104; islandR), and reconciles transmission-network reconstruction with epi metadata. Use when investigating outbreaks for who-infected-whom, defining SNP-cluster outbreak definitions, accounting for unsampled intermediates, choosing between outbreaker2 (rich epi data) and TransPhylo (genomic-only after dated phylogeny), running source attribution between host populations, calling HIV-TRACE thresholds appropriate to the local subtype, or distinguishing recent transmission from reactivation in TB / chronic HIV.

日本語の概要は準備中です。原文の説明を表示しています。

Identifies differential m6A methylation between conditions from MeRIP-seq paired IP/input data using exomePeak2 with `bam_ip` + `bam_input` (control arm) and `bam_treated_ip` + `bam_treated_input` (treatment arm) for integrated GC-bias-aware differential calling (Liu 2022 *NAR Genom Bioinform* 4:lqac046), QNB beta-binomial test (Liu 2017 *BMC Bioinformatics* 18:387), MeTDiff HMM-based differential bundled with MeTPeak, RADAR (Zhang 2019 *Genome Biol* 20:294) with its `filterBins -> diffIP -> reportResult` workflow, and the defensible paired-symmetric case of edgeR / DESeq2 on featureCounts-on-peaks matrices when batch / lot covariates need explicit fixed-effect handling (exomePeak2's top-level API does NOT accept arbitrary covariates). Covers paired vs unpaired vs interaction designs, batch confounding (antibody lot, RNA prep, sequencing run) and the per-lot meta-analysis strategy when exomePeak2 is the primary caller, the stoichiometry-vs-expression-vs-IP-efficiency confound that all MeRIP differential methods inherit, normalisation choice (size factor on IP, on input, on per-sample IP/input ratio), the McIntyre 2020 reproducibility caveat, effect-size filtering as a guardrail against under-powered N=2 designs, and orthogonal-validation routes for absolute stoichiometry (GLORI / SAC-seq / m6Anet `mod_ratio`). Use when comparing m6A levels across two or more conditions, choosing between exomePeak2 / QNB / RADAR / MeTDiff for a given design, handling batch confounding when exomePeak2's API is too rigid, normalising against input properly, distinguishing real hyper- / hypo-methylation from expression-level shifts, applying effect-size thresholds, interpreting volcano plots of differential peaks, or planning a follow-up orthogonal stoichiometry validation.

日本語の概要は準備中です。原文の説明を表示しています。

Infer transcription factor regulons from single-cell RNA-seq with pySCENIC by combining GRNBoost2 co-expression, cisTarget motif-enrichment pruning, and AUCell per-cell activity scoring. Covers the motif-pruning-as-directionality principle, regulon specificity scoring, run-to-run stability, and database/species matching. Use when identifying TF regulons, scoring TF activity per cell, finding master regulators of cell identity, or comparing regulon activity across conditions. For enhancer-driven multiomic GRNs see multiomics-grn; for bulk inference and VIPER protein-activity see grn-inference.

日本語の概要は準備中です。原文の説明を表示しています。

Calls m6A peaks from MeRIP-seq / m6A-seq paired IP-vs-input data using exomePeak2 (transcript-aware, GC-bias-corrected Poisson GLM; Liu 2022 *NAR Genom Bioinform* 4:lqac046), MeTPeak (HMM over sliding windows; Cui 2016 *Bioinformatics* 32:i378), MACS3 / MACS2 with --nomodel --broad --keep-dup all (genome-wide broad alternative), and DRACH motif enrichment confirmation via HOMER or ggseqlogo as a sanity check (NOT a filter). Covers BED12 vs narrowPeak output formats, exonic vs intronic peak handling, multi-tool reconciliation (intersection vs union; cross-caller IDR-equivalent), the m6A-vs-m6Am ambiguity at 5'UTR peaks that antibody-based methods cannot resolve, and orthogonal-validation routes (miCLIP / GLORI / m6A-SAC-seq / m6Anet). Use when calling peaks from paired IP/input genome BAMs, choosing exomePeak2 (transcript-aware default) vs MACS3 (broad genomic) vs MeTPeak (HMM-smoothed low-coverage), confirming DRACH enrichment as a sanity check on the peak set as a whole, reconciling differing peak sets across tools, validating MeRIP peaks against orthogonal single-base methods, interpreting peaks at the 5' end where m6Am contamination is possible, or recommending a multi-tool consensus strategy.

日本語の概要は準備中です。原文の説明を表示しています。